B. Braun has received FDA 510(k) clearance for adding 1 gram and 2 gram Ceflazidime injections within the DUPLEX System, according to a company news release.
The clearance has expanded the number of intravenous therapies the system supports. The 1 and 2 gram Ceflazidime injections can be stored in the DUPLEX System and ready-to-use whenever and wherever it is needed. The DUPLEX System is designed as a two-comparement, flexible, eco-friendly IV container to store pre-measured drug and diluent doses.
Read the release about the new clearance for B. Braun.
More Coverage on B. Braun:
B. Braun Receives Permanent Injunction in Patent Infringement Case
B. Braun Reports 9.8% Sales Growth for FY 2010
B. Braun Announces FDA Approval of OTC Wound Management Gel
The clearance has expanded the number of intravenous therapies the system supports. The 1 and 2 gram Ceflazidime injections can be stored in the DUPLEX System and ready-to-use whenever and wherever it is needed. The DUPLEX System is designed as a two-comparement, flexible, eco-friendly IV container to store pre-measured drug and diluent doses.
Read the release about the new clearance for B. Braun.
More Coverage on B. Braun:
B. Braun Receives Permanent Injunction in Patent Infringement Case
B. Braun Reports 9.8% Sales Growth for FY 2010
B. Braun Announces FDA Approval of OTC Wound Management Gel